Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed CFO
Quarterly results
Director departure
Appointed director
|
|
Aceragen, Inc. (IDRA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Aceragen, Inc.|
Txns:
| Sold 51 shares
@ $0.51, valued at
$26 |
|
| 08/11/2023 |
4
| MILANO VINCENT (Director) has filed a Form 4 on Aceragen, Inc.|
Txns:
| Sold 3,283 shares
@ $0.5331, valued at
$1.8k
|
|
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Pillar Invest Corp (10% Owner) has filed a Form 4 on Aceragen, Inc.|
Txns:
| Sold 3,605 shares
@ $1.58, valued at
$5.7k
Sold 2,213 shares
@ $1.54, valued at
$3.4k
|
|
| 05/18/2023 |
4
| Chopra Atul (10% Owner) has filed a Form 4 on Aceragen, Inc.|
Txns:
| Sold 6,887 shares
@ $1.4, valued at
$9.6k
Sold 6,645 shares
@ $1.41, valued at
$9.4k
Sold 8,469 shares
@ $1.42, valued at
$12k
Sold 1,220 shares
@ $1.43, valued at
$1.7k
Sold 3,369 shares
@ $1.44, valued at
$4.9k
Sold 701 shares
@ $1.45, valued at
$1k
Sold 48 shares
@ $1.46, valued at
$70.1
Sold 50 shares
@ $1.47, valued at
$73.5
Sold 312 shares
@ $1.48, valued at
$461.8
Sold 1,415 shares
@ $1.49, valued at
$2.1k
Sold 5,503 shares
@ $1.5, valued at
$8.3k
|
|
| 05/18/2023 |
4
| Chopra Atul (10% Owner) has filed a Form 4 on Aceragen, Inc.|
Txns:
| Sold 23,890 shares
@ $1.5, valued at
$35.8k
Sold 7,162 shares
@ $1.51, valued at
$10.8k
Sold 4,676 shares
@ $1.52, valued at
$7.1k
Sold 6,310 shares
@ $1.53, valued at
$9.7k
Sold 3,199 shares
@ $1.54, valued at
$4.9k
Sold 2,075 shares
@ $1.55, valued at
$3.2k
Sold 954 shares
@ $1.56, valued at
$1.5k
Sold 2,055 shares
@ $1.58, valued at
$3.2k
Sold 1,865 shares
@ $1.59, valued at
$3k
Sold 16,338 shares
@ $1.6, valued at
$26.1k
Sold 4,603 shares
@ $1.61, valued at
$7.4k
|
|
| 05/18/2023 |
4
| Chopra Atul (10% Owner) has filed a Form 4 on Aceragen, Inc.|
Txns:
| Sold 3,734 shares
@ $1.75, valued at
$6.5k
Sold 50 shares
@ $1.76, valued at
$88
Sold 81 shares
@ $1.77, valued at
$143.4
Sold 5,737 shares
@ $1.78, valued at
$10.2k
Sold 4,151 shares
@ $1.79, valued at
$7.4k
Sold 3,301 shares
@ $1.8, valued at
$5.9k
Sold 700 shares
@ $1.81, valued at
$1.3k
Sold 1,800 shares
@ $1.82, valued at
$3.3k
Sold 2,000 shares
@ $1.83, valued at
$3.7k
Sold 4,500 shares
@ $1.84, valued at
$8.3k
Sold 1,500 shares
@ $1.85, valued at
$2.8k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2023 |
4
| JORDAN ANDREW R (Chief Strategy Officer) has filed a Form 4 on Aceragen, Inc.|
Txns:
| Exercised 6,843 options to buy
@ $0 |
|
| 01/19/2023 |
4
| WOOTEN RONALD J (Director) has filed a Form 4 on Aceragen, Inc.|
Txns:
| Converted 14,115 warrants
@ $460, valued at
$6.5M
Converted 830,294 warrants
@ $7.82, valued at
$6.5M
|
|
| 01/19/2023 |
4
| Salain Daniel (COO) has filed a Form 4 on Aceragen, Inc.|
Txns:
| Exercised 22,810 options to buy
@ $0 |
|
| 01/19/2023 |
4
| Kraus Carl N (Chief Medical Officer) has filed a Form 4 on Aceragen, Inc.|
Txns:
| Exercised 440,844 options to buy
@ $208.76, valued at
$92M
|
|
| 01/19/2023 |
4
| Taylor John Clayton (CEO) has filed a Form 4 on Aceragen, Inc.|
Txns:
| Exercised 22,810 options to buy
@ $0 |
|
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
4
| DOUGHERTY MICHAEL R (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 33,523 shares
@ $0.44, valued at
$14.8k
|
|
| 01/10/2023 |
4
| JORDAN ANDREW R (CHIEF STRATEGY OFFICER) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 261,718 shares
@ $0
Paid exercise price by delivering 73,940 shares
@ $0.7099, valued at
$52.5k
|
|
| 01/10/2023 |
4
| Lim Bryant David (SVP AND GENERAL COUNSEL) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 399,218 shares
@ $0
Paid exercise price by delivering 119,957 shares
@ $0.7099, valued at
$85.2k
|
|
| 01/10/2023 |
4
| Kirby John J. (CFO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 399,218 shares
@ $0
Paid exercise price by delivering 119,957 shares
@ $0.7099, valued at
$85.2k
|
|
| 10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2022 |
4
| Pillar Invest Corp (10% Owner) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Exercised (in-or-at-the-money) 1,533,159 options to buy
@ $0.01, valued at
$15.3k
|
|
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| SOLAND DANIEL B (COO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 66,500 options to buy
@ $0.4327, valued at
$28.8k
|
|
| 07/07/2022 |
4
| MILANO VINCENT (PRESIDENT AND CEO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 124,000 options to buy
@ $0.4327, valued at
$53.7k
|
|
|
|
|